Sarcomatoid Mesothelioma
📧 Sign up to get email alerts when something new happens for Sarcomatoid Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pemetrexed disodium with cisplatin, with or without cediranib, in malignant pleural mesothelioma; result…
-
CLINICAL_TRIALS trial_result · 2016-10-24Clinical Trial Update: Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma [Phase 2]
A Phase 2 trial of tivantinib in previously treated malignant mesothelioma was terminated, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2014-12-29Clinical Trial Update: PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial update for belinostat (PXD101) as second-line therapy in unresectable malignant mesothelioma; study completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma [Phase 2]
Phase 2 trial evaluating chemotherapy with or without bevacizumab for malignant mesothelioma has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-05Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma. [Phase 2]
Phase 2 trial update of sorafenib tosylate in malignant mesothelioma has completed (status: COMPLETED).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.